SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, today announced that the Chief Executive Officer of Boundless Bio, Zachary Hornby, will present at the Piper Sandler 33rd Annual Virtual Healthcare Conference and the Evercore ISI 4th Annual HealthCONx Conference. Presentation details are as follows:
Piper Sandler 33rd Annual Virtual Healthcare Conference
Date: Pre-recorded presentation accessible on Monday, November 22, 2021
Time: 10:00 a.m. ET / 7:00 a.m. PST
Evercore ISI 4th Annual HealthCONx Conference
Date: Live presentation on Wednesday, December 1, 2021
Time: 1:50 p.m. ET / 10:50 a.m. PST
About Boundless Bio
Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.
For more information, visit www.boundlessbio.com.